Cancer: Priming cancer cells for death

Science

Volumn 334, Issue 6059, 2011, Pages 1075-1076

  Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN BCL 2;

CANCER; CELL ORGANELLE; CHEMOTHERAPY; ENZYME ACTIVITY; GENETIC ANALYSIS; GENOME; MITOCHONDRION; PHYSIOLOGICAL RESPONSE; PROTEIN;

APOPTOSIS; CANCER CELL; CELL ADHESION; CELL DEATH; CHEMOSENSITIVITY; HUMAN; IN VITRO STUDY; LEUKEMIA CELL LINE; MEMBRANE DEPOLARIZATION; MEMBRANE PERMEABILITY; MITOCHONDRION; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

EID: 82255173974     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1215568     Document Type: Review

References (18)

1. T. Ni Chonghaile et al., Science 334, 1129 (2011).
2. R. J. Youle, A. Strasser, Nat. Rev. Mol. Cell Biol. 9, 47 (2008).
3. C. L. Sentman, J. R. Shutter, D. Hockenbery, O. Kanagawa, S. J. Korsmeyer, Cell 67, 879 (1991).
4. T. Miyashita, J. C. Reed, Cancer Res. 52, 5407 (1992).
5. J. E. Chipuk, D. R. Green, Trends Cell Biol. 18, 157 (2008).
6. J. C. Reed, Cell 91, 559 (1997).
7. Y. B. Chen et al., J. Cell Biol. 195, 263 (2011).
8. C. Cárdenas et al., Cell 142, 270 (2010).
9. Y. P. Rong et al., Mol. Cell 31, 255 (2008).
10. S. W. Fesik, Cell 103, 273 (2000).
11. E. Gavathiotis, D. E. Reyna, M. L. Davis, G. H. Bird, L. D. Walensky, Mol. Cell 40, 481 (2010).
12. M. B. Meads, L. A. Hazlehurst, W. S. Dalton, Clin. Cancer Res. 14, 2519 (2008).
13. M. Konopleva, Y. Tabe, Z. Zeng, M. Andreeff, Drug Resist. Updat. 12, 103 (2009).
14. I. Munk Pedersen, J. C. Reed, Leuk. Lymphoma 45, 2365 (2004).
15. J. C. Reed, M. Pellecchia, Blood 106, 408 (2005).
16. E. J. Dean et al., Neoplasia 13, 339 (2011).
17. L. Gandhi et al., J. Clin. Oncol. 29, 909 (2011).
18. J.C.R. and the Sanford-Burnham Medical Research Institute hold patents and patent applications on chemical inhibitors of Bcl-2 family proteins, some of which have been licensed to a public company, Oncothyreon Inc.